Inventor · disambiguated record
Shyam B. Karki
Also filed as: KARKI SHYAM · KARKI SHYAM B · KARKI SHYAM BABU
10 granted patents·16 pending applications·15 citations·filing 2000–2024
83Inventor score
Top patents by PatentIndex Score
26 records- 0181US11033509B2Pharmaceutical bead formulations comprising dimethyl fumarateBIOGEN MA INC·Filed 2017·Granted Jun 15, 2021·2 cites·21 claims
- 0280US11291642B2Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2016·Granted Apr 5, 2022·2 cites·14 claims
- 0376US12064427B2Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the sameCELGENE CORP·Filed 2023·Granted Aug 20, 2024·0 cites·23 claims
- 0474US2024358697A1Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the sameCELGENE CORP·Filed 2024·Application pending·0 cites
- 0572US6355611B1Salt form of a conjugate useful in the treatment of prostate cancerMERCK & CO INC·Filed 2000·Granted Mar 12, 2002·7 cites·31 claims
- 0671US6656942B2Orally active salts with tyrosine kinase activityMERCK & CO INC·Filed 2001·Granted Dec 2, 2003·4 cites·11 claims
- 0767US10172794B2Controlled release dosage form for once daily administration of dimethyl fumarateBIOGEN MA INC·Filed 2014·Granted Jan 8, 2019·0 cites·6 claims
- 0862US2022362195A1Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 0961US11779580B2Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using theCELGENE CORP·Filed 2020·Granted Oct 10, 2023·0 cites·62 claims
- 1061US2019091146A1Controlled Release Dosage Form for Once Daily Administration of Dimethyl FumarateBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 1159US2021369629A1Pharmaceutical bead formulations comprising dimethyl fumarateBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1251US2006093666A1Formulations for tyrosine kinase inhibitorsKARKI SHYAM B·Filed 2004·Application pending·0 cites
- 1351US2019008768A1Controlled Release Dosage Form for Once Daily Administration of Dimethyl FumarateBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 1450US6960590B2Orally active salts with tyrosine kinase activityMERCK & CO INC·Filed 2001·Granted Nov 1, 2005·0 cites·5 claims
- 1548US2019175510A1Pharmaceutical matrix formulations comprising dimethyl fumarateBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1647US6979676B2Pharmaceutical composition containing and indolopyrrolocarbazole derivativeBANYU PHARMA CO LTD·Filed 2002·Granted Dec 27, 2005·0 cites·6 claims
- 1745US2004213850A1Sustained release delivery of a thrombin inhibitorFiled 2004·Application pending·0 cites
- 1845US2004067216A1Hiv protease inhibitors supported on cation exchange resins for oral administrationFiled 2002·Application pending·0 cites
- 1942US2005113577A1Solid forms of slats with tyrosine kinase activityFiled 2003·Application pending·0 cites
- 2039US2004023978A1Active salt forms with tyrosine kinase activityREN YU·Filed 2003·Application pending·0 cites
- 2139US2006019933A1Process for preparing stabilized vitamin DBOARDMAN DAVID·Filed 2005·Application pending·0 cites
- 2239US2019083404A1Pharmaceutical matrix formulations comprising dimethyl fumarateBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 2338US2004023981A1Salt forms with tyrosine kinase activityFiled 2003·Application pending·0 cites
- 2435US2015352077A1Multi-Component Crystalline Particles for Inhalation TherapyPROSONIX LTD·Filed 2014·Application pending·0 cites
- 2534US2018289655A1Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological DiseasesBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2633US11197842B2Pharmaceutical bead formulations comprising dimethyl fumarateBIOGEN MA INC·Filed 2015·Granted Dec 14, 2021·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →